Thyrocare Technologies is currently trading at Rs. 682.00, up by 9.45 points or 1.41% from its previous closing of Rs. 672.55 on the BSE.
The scrip opened at Rs. 683.00 and has touched a high and low of Rs. 692.00 and Rs. 674.00 respectively. So far 67,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 779.90 on 06-Apr-2017 and a 52 week low of Rs. 548.90 on 29-Aug-2016.
Last one week high and low of the scrip stood at Rs. 715.25 and Rs. 670.00 respectively. The current market cap of the company is Rs. 3,663.94 crore.
The promoters holding in the company stood at 63.96%, while non-institutions held 36.04% stake in the company.
Venture Capital firm Norwest Venture Partners has offloaded 9.3 per cent stake in diagnostics chain Thyrocare Technologies for an estimated over Rs 335 crore through open market transactions. The shares were picked by Reliance Mutual Fund and Birla Sunlife Mutual Fund, among others.
Norwest Venture Partners VII-A-Mauritius has sold a total of 50 lakh shares of the company in a price range of Rs 670- 670.88 apiece.
Thyrocare Technologies is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7000.00 |
Max Healthcare Inst | 1008.35 |
Narayana Hrudayalay | 1265.30 |
Aster DM Healthcare | 442.70 |
Global Health | 1105.25 |
View more.. |